Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia

被引:78
作者
Caballero-Granado, FJ
Becerril, B
Cuberos, L
Bernabeu, M
Cisneros, JM
Pachón, J
机构
[1] Hosp Univ Virgen Rocio, Serv Enfermedades Infecciosas, Seville, Spain
[2] Hosp Univ Virgen Rocio, Microbiol Serv, Seville, Spain
关键词
D O I
10.1086/318717
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mortality rate of patients with cases of enterococcal bacteremia is high, although it has often been related to the patients' underlying conditions rather than to the infection itself. To analyze the attributable prognosis of enterococcal bacteremia (assessed by its attributable mortality rate and duration of hospital stay), a prospective, matched case-control study was done. All adults with an episode of enterococcal bacteremia without endocarditis were included. A control patient was randomly selected for every case patient and matched by sex, age and hospital ward. Univariate and multivariate analyses were performed. A total of 122 pairs were included, and incidence of enterococcal bacteremia was 2.3 episodes/1000 discharges. Crude 30-day mortality rates for case patients and control patients were 23% and 17%, respectively (P = .29); thus, the estimated attributable mortality rate was 6% (95% confidence interval, -4% to 16%). The mean duration of hospital stay of case patients and control patients were 38 and 17 days, respectively (P<.001); thus, the estimated attributable duration of hospital stay was 21 days (95% CI, 7-32 days). Enterococcal bacteremia without endocarditis does not increase risk of death by itself but extends the duration of hospital stay of patients who develop it.
引用
收藏
页码:587 / 594
页数:8
相关论文
共 42 条
  • [1] BARRALL DT, 1985, ARCH SURG-CHICAGO, V120, P57
  • [2] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [3] BRYAN CS, 1985, SURG GYNECOL OBSTET, V160, P557
  • [4] Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin
    Caballero-Granado, FJ
    Cisneros, JM
    Luque, R
    Torres-Tortosa, M
    Gamboa, F
    Díez, F
    Villanueva, JL
    Pérez-Cano, R
    Pasquau, J
    Merino, D
    Menchero, A
    Mora, D
    López-Ruz, MA
    Vergara, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) : 520 - 525
  • [5] CARRASCO JL, 1993, ESTADISTICA MULTIVAR, P3
  • [6] CARTON JA, 1993, MED CLIN-BARCELONA, V101, P769
  • [7] CELIS G, 1988, ENFERM INFECC MICROB, V6, P454
  • [8] COAGULASE-NEGATIVE STAPHYLOCOCCAL BACTEREMIA WITH SPECIAL REFERENCE TO SEPTIC SHOCK - EXPERIENCE IN AN INTENSIVE-CARE UNIT
    DAHMASH, NS
    CHOWDHURY, MNH
    FAYED, DF
    [J]. JOURNAL OF INFECTION, 1994, 29 (03) : 295 - 303
  • [9] DOUGHERTY SH, 1983, ARCH SURG-CHICAGO, V118, P232
  • [10] INCREASING PROBLEMS IN THE THERAPY OF ENTEROCOCCAL INFECTIONS
    ELIOPOULOS, GM
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (06) : 409 - 412